XML 16 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 13, 2023
Jun. 30, 2022
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Registrant Name CATALYST PHARMACEUTICALS, INC    
Entity Central Index Key 0001369568    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity Filer Category Accelerated Filer    
Trading Symbol CPRX    
Entity Emerging Growth Company false    
Entity Small Business false    
Entity Address, State or Province FL    
Entity Interactive Data Current Yes    
Title of 12(b) Security Common Stock    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   105,654,395  
Entity Tax Identification Number 76-0837053    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 355 Alhambra Circle    
Entity Address, Address Line Two Suite 801    
Entity Address, City or Town Coral Gables    
Entity Address, Postal Zip Code 33134    
City Area Code 305    
Local Phone Number 420-3200    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-33057    
Entity Public Float     $ 665,590,948
ICFR Auditor Attestation Flag true    
Auditor Name GRANT THORNTON LLP    
Auditor Firm ID 248    
Auditor Location Miami, Florida